AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue of
PONTE VEDRA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of
MIAMI, Nov. 03, 2026 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for November 2026 of $0.08 per share, comprised of a $0.04 per share base
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative and broadly accessible pipeline of induced pluripotent stem cell (iPSC)-derived
Company commits to independent board oversight; Preserves all shareholders’ positions by rescinding proposed reverse split FAIRFAX, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — Visium Technologies, Inc. (OTC: VISM) (“Visium” or the “Company”),
Executing Against Transformational ROI Strategy for Long-Term Value Creation Reaffirming Full Year 2026 Outlook RESTON, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — comScore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting
RADNOR, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) — Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the UBS Global Healthcare Conference on Tuesday,
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026.
DRAPER, Utah, Nov. 03, 2026 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed
Follow